Announcements Trials
Browse Landscape

Phase

Phase NA 21Phase 2 16Phase 3 3Phase 4 2Phase 2/3 2Phase 1/2 1Phase 1 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 16OTHER_GOV 2NIH 2FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 9Papillomavirus Infections 4Lymphoma, Non-Hodgkin 4Hypertension, Portal 4Febrile Neutropenia 4Carcinoma, Non-Small-Cell Lung 4Polycystic Ovary Syndrome 3Ovarian Cysts 3Multiple Myeloma 3Lung Neoplasms 3Cancer Pain 3Adenomatous Polyposis Coli 3Recurrence 2Rectal Neoplasms 2Prostatic Hyperplasia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Neoplasms 2Lymphoma, B-Cell 2Lymphoma 2Liver Cirrhosis 2Leiomyoma 2Infertility 2Hyperthermia 2Hematologic Neoplasms 2Esophageal Neoplasms 2Vomiting 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Surgical Wound Infection 1

Interventions

Radiotherapy 2XELOX 1Consolidation Chemotherapy 1Chemotherapy, Adjuvant 1Chemoradiotherapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × OTHER_GOV × Rectal Neoplasms × Clear all
NCT07483060 2026-03-19

NG-ST

Vastra Gotaland Region

Phase 4 Not yet recruiting
90 enrolled
Gastrointestinal

Rectal Neoplasms

NCT04747951 2021-02-15

Total Neoadjuvant Therapy in Rectal Cancer Treatment

State Scientific Centre of Coloproctology, Russian Federation

Phase 4 Unknown
280 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡